# Remifentanil and Remimazolam to Limit Patient Movement

> **NCT06583811** · NA · RECRUITING · sponsor: **Egymedicalpedia** · enrollment: 70 (estimated)

## Conditions studied

- Long-Eye Surgeries

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT06583811
- **Lead sponsor:** Egymedicalpedia
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-10
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06583811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06583811, "Remifentanil and Remimazolam to Limit Patient Movement". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06583811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*